logo
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer

National Post27-05-2025

Article content
NEW YORK — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the 'Company' or 'MindMed'), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Brandi L. Roberts as its Chief Financial Officer (CFO), effective June 2, 2025. In her new role, Ms. Roberts will join MindMed's executive leadership team where she will oversee all aspects of financial strategy, capital planning, accounting, investor relations and information technology as the Company advances its clinical development and commercial priorities for its lead product candidate MM120 orally disintegrating tablet (ODT) for generalized anxiety disorder (GAD) and major depressive disorder (MDD).
Article content
Article content
'Brandi joins MindMed at a pivotal moment for the company, bringing with her a powerful combination of financial acumen, strategic vision, and deep biotech sector expertise,' said Rob Barrow, Chief Executive Officer of MindMed. 'Her proven track record leading public companies through transformative milestones, including initial public offerings (IPO), business development and investor engagement makes her a valuable addition to our organization. As we accelerate toward the potential commercialization of MM120 ODT, her understanding of the healthcare landscape and executional strength will be instrumental in advancing our strategy, driving growth, and delivering long-term value for both patients and shareholders.'
Article content
'MindMed is leading a true paradigm shift in mental health treatment, and I'm excited to collaborate with a team renowned for its exceptional depth and breadth of experience in drug development,' said Ms. Roberts. 'With MM120 ODT, the company is advancing a potential breakthrough for the millions of people in the U.S. suffering from GAD and MDD. Joining MindMed is an extraordinary opportunity to continue building a robust financial infrastructure that matches the strength of the Company's science; delivering a comprehensive strategic financial vision built to support innovation, agility, and access with the goal of helping patients and making a meaningful impact in addressing the mental health crisis.'
Article content
Ms. Roberts has more than 25 years of financial leadership experience within the life sciences industry. Most recently, she served as CFO and Executive Vice President of Longboard Pharmaceuticals, where she helped lead the company through its IPO, multiple financings, and ultimately, its $2.6 billion acquisition by Lundbeck in 2024. Throughout her career, Ms. Roberts has played pivotal roles in scaling operations, supporting clinical development, and managing investor relations with leading investors, funds, and analysts. She has held CFO roles at Lineage Cell Therapeutics, REVA Medical, and Mast Therapeutics, and senior finance positions at Alphatec Spine, Inc., Artes Medical, Inc., Stratagene Corporation, and Pfizer, Inc. Ms. Roberts received her MBA from the University of San Diego and her B.S. degree in business administration in Accounting and Finance from the University of Arizona. She is a Certified Public Accountant in the State of California and currently serves on the board of advisors for Life Science Cares San Diego and the board for the Association of Bioscience Financial Officers Southwest chapter.
Article content
In connection with her appointment as Chief Financial Officer on June 2, 2025, MindMed will grant Ms. Roberts on such date inducement awards consisting of (i) an option to purchase 500,000 common shares of the Company (the 'Option') and (ii) 125,000 performance share units (the 'PSUs') (assuming achievement at target levels of performance) that, if earned, will be settled in MindMed common shares upon vesting. The Option will have an exercise price equal to the closing price of MindMed's common shares on May 30, 2025, the last trading day on which MindMed's common shares will trade prior to the date of the grant and will vest over a four-year period with 25% vesting on the first anniversary and the remaining 75% vesting in 36 equal monthly installments over the three-year period thereafter, subject to her continued employment. The PSUs will vest on the third anniversary of the grant date, subject to continued service through the vesting date. Actual earned PSUs can range from 0%-200% of the target number of PSUs and will be based on the achievement of certain performance metrics as measured at the end of the three-year performance period.
Article content
The inducement awards to Ms. Roberts will be granted as a material inducement to her entering into employment with MindMed and were approved by MindMed's Compensation Committee on May 21, 2025, in accordance with Rule 5635(c)(4) of The NASDAQ Stock Market LLC. The awards were granted outside MindMed's equity incentive plans.
Article content
MindMed is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health. MindMed trades on NASDAQ under the symbol MNMD.
Article content
Forward-Looking Statements
Article content
Certain statements in this news release related to the Company constitute 'forward-looking information' within the meaning of applicable securities laws and are prospective in nature. Forward-looking information is not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as 'will', 'may', 'should', 'could', 'intend', 'estimate', 'plan', 'anticipate', 'expect', 'believe', 'potential' or 'continue', or the negative thereof or similar variations. Forward-looking information in this news release includes, but is not limited to, statements regarding the Company's beliefs regarding potential benefits of MM120 ODT for GAD and MDD; the size of the addressable market for MM120 ODT for treatment of GAD and MDD; the Company's plans to appoint Ms. Roberts as CFO effective June 2, 2025, and to grant her inducements awards in connection therewith. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information, including history of negative cash flows; limited operating history; incurrence of future losses; availability of additional capital; compliance with laws and regulations; legislative and regulatory developments, including decisions by the Drug Enforcement Administration and states to reschedule any of our product candidates, if approved, containing Schedule I controlled substances, before they may be legally marketed in the U.S.; difficulty associated with research and development; risks associated with clinical studies or studies; heightened regulatory scrutiny; early stage product development; clinical study risks; regulatory approval processes; novelty of the psychedelic inspired medicines industry; ability to maintain effective patent rights and other intellectual property protection; as well as those risk factors discussed or referred to herein and the risks, uncertainties and other factors described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025 under headings such as 'Special Note Regarding Forward-Looking Statements,' and 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' and other filings and furnishings made by the Company with the securities regulatory authorities in all provinces and territories of Canada which are available under the Company's profile on SEDAR+ at www.sedarplus.ca and with the U.S. Securities and Exchange Commission on EDGAR at www.sec.gov. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events, changes in expectations or otherwise.
Article content
Article content
Article content
Article content
Article content

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Company that worked on ArriveCan app barred from government contracts for 7 years
Company that worked on ArriveCan app barred from government contracts for 7 years

CBC

timean hour ago

  • CBC

Company that worked on ArriveCan app barred from government contracts for 7 years

Ottawa says it has banned the largest contractor that worked on the ArriveCan app from entering into contracts or real property agreements with the government for seven years. Public Services and Procurement Canada has announced that GC Strategies Inc. has been deemed "ineligible" after an assessment of the supplier's conduct. Last year, the department suspended the security status of GC Strategies, which the auditor general says was awarded more than $19 million for the project. That move followed an earlier decision to suspend the company from procurement processes within the department. The government also barred two other companies that contributed to the ArriveCan project, Dalian Enterprises and Coradix Technology Consulting, from participating in procurement opportunities. The federal government launched the app in April 2020 as a way to track health and contact information for people entering Canada during the COVID-19 pandemic, as well as to digitize customs and immigration declarations. A report by Canada's Auditor General Karen Hogan found the government's record-keeping was poor and its reliance on outside contractors allowed the cost of the project to balloon to $60 million. The first ArriveCan contract was initially valued at just $2.35 million. On Tuesday, Hogan is set to deliver an audit focusing on whether the contracts awarded and the payments made to GC Strategies and other incorporated companies were "in accordance with applicable policy instruments" and were good value for money. Public Services and Procurement Canada says the government continues to take action to "strengthen the integrity of the procurement process." The Canadian Press has reached out to GC Strategies and to Public Services and Procurement Canada for comment. GC Strategies partner Kristian Firth was ordered to appear before the bar of the House of Commons last year after refusing to answer questions at a committee hearing. Firth was grilled by MPs for two hours, though Liberals opted out of questioning after a doctor's note provided to the clerk of the House recommended that he not appear because of mental-health issues. GC Strategies did not develop or manage the ArriveCan app, but it was tasked by the federal government to assemble a team to complete some parts of the project.

Silver's Options Sizzle: Are Traders Betting on a Breakout?
Silver's Options Sizzle: Are Traders Betting on a Breakout?

Globe and Mail

time2 hours ago

  • Globe and Mail

Silver's Options Sizzle: Are Traders Betting on a Breakout?

A notable wave of trading activity swept through several silver-linked assets in early June. Investors saw a significant jump in call option volumes for multiple silver-related equities. Call options give the holder the right, not the requirement, to buy an asset, such as a stock or ETF share, at a pre-set price by a specific date. When call volume spikes, it often signals that some traders believe the asset's price is poised to rise. This unusual call option volume and increased investor interest in multiple stocks and ETFs at the same time warrant a closer look to see what's stirring in the silver sector. Unpacking the Action: A Look at Specific Silver Plays The heightened call option volume in early June varied across multiple silver-related securities, each telling a slightly different story. Separately, they tell four stories of bullish catalysts and heightened investor sentiment, but when combined, they start to reveal the bigger picture of a sector accumulating interest and investment. iShares Silver Trust: A Price Play on Silver Bullion? [content-module:CompanyOverview|NYSE:AG] The iShares Silver Trust (NYSEARCA: SLV), an ETF that aims to track the price of silver bullion, saw 599,279 call option contracts traded. This volume was 57.8% above its usual average. The high call volume may suggest that some traders expect silver prices to rebound soon or are preparing for further price fluctuations. Because SLV tracks physical silver, this option's activity directly reflects views on the metal itself, likely influenced by broader economic news or general market coverage. First Majestic: Mining News Ignites Options Interest? [content-module:CompanyOverview|NYSE:AG] First Majestic Silver Corp. (NYSE: AG), a company focused mainly on silver production, experienced a call option volume of 39,607 contracts, an 80.9% increase from its average. First Majestic's stock price has also climbed around 18% to $7.28 during the first week of June, with a high trading volume. This mix of soaring call options, a rising stock price, and heavy trading often points to strong positive sentiment. Recent good news from the company has also likely played a role. For instance, on May 28, 2025, First Majestic announced a significant gold-silver discovery at its Santa Elena property. This, along with strong financial results from the first quarter of 2025, could lead traders to expect more gains from the stock. Pan American Silver: Big Deal Draws Options Traders? [content-module:CompanyOverview|NYSEARCA:SILJ] Pan American Silver Corp. (NYSE: PAAS), a large, diversified silver producer, recorded 9,098 call option contracts traded, up 25.7% from its average. The company's stock price also rose, gaining nearly 10% in early June. This increased call activity, alongside positive news indicators, suggests investors are reacting well to recent company moves. A key factor is likely Pan American's May 11, 2025, announcement of a deal to acquire MAG Silver Corp. for $2.1 billion. This strategic acquisition is expected to significantly boost Pan American's silver output and potential future earnings, which could, in turn, lift its stock price and attract optimistic options bets. Junior Miners: High Hopes for Smaller Players? [content-module:CompanyOverview|NYSEARCA:SILJ] The Amplify Junior Silver Miners ETF (NYSEARCA: SILJ), which holds smaller silver mining and exploration companies, saw its call option volume hit 14,925 contracts. This was a striking 97.7% leap above its average, and it was also the most significant percentage increase among these assets. SILJ's price also increased by around 10% in early June. This dramatic percentage jump in calls for SILJ points to strong speculative interest in this part of the silver market. Junior miners often have stock prices that move more sharply with silver prices. The high option activity here suggests that some traders may be betting on substantial returns from these smaller firms if silver prices continue to climb or if positive news persists for the sector. Beyond Options: What This Means for the Silver Market When call option volume rises sharply across different types of silver assets, it can signal a broader increase in investor focus on the entire silver sector. Some traders may be positioning for potential price gains. Silver's appeal comes from several areas. Demand from industries utilizing silver in green technologies, such as solar panels, electronics and the automotive sector, remains strong. Silver is also a well-known precious metal. It is often regarded as a valuable investment that retains its value, especially during economic uncertainty or rising inflation. These core factors continue to support interest in the metal. What Spiking Call Volumes Say About Silver's Next Move The notable surge in call option activity across our four assets in early June clearly shows heightened investor focus on the silver sector. This flurry of bullish bets, reflected in the increased demand for call options, suggests that a market segment is positioning for potential upward price movements in silver bullion and mining equities. Whether driven by specific company news or broader shifts in sentiment towards precious metals, the data points to a renewed speculative interest. The significant percentage increase in call volume underscores a willingness among some traders to embrace higher-risk, potentially higher-reward scenarios within the silver space. Ultimately, this concentrated options activity serves as a strong indicator that silver and its related securities captured significant market attention. At the same time, the direct motivations behind each trade can vary, the collective signal points towards a period of dynamic interest and re-evaluation for the silver complex. How these expectations play out will depend on ongoing market fundamentals, company performance, and the broader economic landscape, ensuring that the silver narrative will remain one to watch. Where Should You Invest $1,000 Right Now? Before you make your next trade, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

BCE Inc: Analyst Update & Analysis
BCE Inc: Analyst Update & Analysis

Globe and Mail

time2 hours ago

  • Globe and Mail

BCE Inc: Analyst Update & Analysis

BCE Inc. (BCE:CA) (BCE) National Bank Financial has maintained its 'Outperform' rating for BCE Inc., adjusting its 12-month price target to CAD 35 from CAD 36. This revision reflects a cautious outlook amid ongoing challenges in the telecommunications sector. Analyst Adam Shine's updated forecast for BCE's FY2025 earnings per share is CAD 2.70, slightly down from the previous estimate of CAD 2.71. This adjustment aligns with broader concerns over the company's financial health, including high leverage and dividend sustainability. Despite these challenges, BCE continues to offer a substantial dividend yield, which remains a key attraction for income-focused. Stock Forecast & Analysis According to the stock forecast from 12 analysts, the average 12-month target price for BCE Inc. is CAD 34.94. This represents a potential upside of approximately 17% from its most recent closing price of CAD 29.87. However, the average analyst rating is a 'Hold,' indicating a neutral stance on the stock. Analysts see limited near-term catalysts for significant growth, suggesting that investors should not expect major upside in the short term. Stock Target Advisor's independent fundamental analysis paints a more negative picture, rating BCE Inc. as 'Bearish.' This rating is based on three positive signals and eleven negative signals. The bearish assessment reflects concerns about the company's financial fundamentals, which likely include high levels of debt, weak earnings growth, and pressure on revenue. There are also likely worries about BCE's ability to sustain its dividend amid high capital expenditure and broader challenges in the Canadian telecom sector. Despite some recent signs of stabilization, BCE's share performance over the past year has been notably weak. The stock has gained 0.54% over the past week and 1.12% over the past month, but these small increases follow a steep decline of 36.78% over the past year. This long-term drop has been driven by factors such as rising interest rates, which reduce the appeal of dividend-paying stocks, concerns about the sustainability of BCE's dividend, and regulatory and competitive pressures affecting the Canadian telecom industry. In summary, while BCE Inc. still offers an attractive dividend and maintains its role as a defensive telecom stock, analysts and technical models remain cautious. With a 'Hold' rating consensus and bearish sentiment from algorithmic analysis, the company may struggle to regain investor confidence until it demonstrates more stable earnings, improved growth prospects, or clarity around its long-term capital strategy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store